Bluejay Diagnostics share price logo

Bluejay Diagnostics

NASDAQ: BJDX

$0.86

+0.05

(+6.45%)

Live

as on

Bluejay Diagnostics Stock Performance

as on September 18, 2026 at 1:11 am IST

  • Day's Low

    Day's High

    $0.81
    $0.87
    downward going graph

    6.35%

    Downside

    0.59%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.80
    $16.68
    downward going graph

    7.48%

    Downside

    1828.55%

    Upside

    downward going graph

Bluejay Diagnostics share price movements today

Previous Close
$0.81
Open
$0.83
Volume
47.7K
Market Cap
$877.0K
Day's Low - High
$0.81 - $0.87
52 Week Low - High
$0.80 - $16.68

Bluejay Diagnostics Historical Returns

1 Month Return
-20.34 %
3 Month Return
-81.7 %
1 Year Return
-86.9 %
3 Year Return
-99.98 %
5 Year Return
0 %

Bluejay Diagnostics Stock Fundamentals & Key Indicators

Check Bluejay Diagnostics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$877.0K

EPS (TTM)

-11.8

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.07

Industry PE ratio

-2.00

PEG Ratio

-0.00021177255364855234

EBITDA

-7.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-125.01%

Bluejay Diagnostics Stock Valuation

Track how Bluejay Diagnostics P/E has moved over time to understand its valuation trends.

Bluejay Diagnostics in the last 5 years

  • Overview

  • Trends

Lowest (-690.23x)

December 31, 2021

Industry (-2.00x)

December 31, 2025

Today (-0.18x)

December 31, 2025

Highest (-0.12x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.18x

Bluejay Diagnostics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bluejay Diagnostics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$877.0KNA-0.070.00%0.00%
BUY$49.4B-25.24%49.2877.98%0.00%
BUY$120.0B-28.6%22.2466.69%3.04%
BUY$178.4B-19.27%32.8156.80%2.43%
BUY$105.7B1.72%28.3265.17%1.26%

Stock Returns calculator for Bluejay Diagnostics Stock including INR - Dollar returns

The Bluejay Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bluejay Diagnostics investment value today

Current value as on today

₹15,227

Returns

-₹84,773

(-84.77%)

Returns from Bluejay Diagnostics Stock

-₹86,050 (-86.05%)

Dollar Impact

₹1,277 (+1.28%)

Analyst Recommendation on Bluejay Diagnostics Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Bluejay Diagnostics. Average target price of $256

Bluejay Diagnostics Share Price Target

Get share price movements and forecasts by analysts on Bluejay Diagnostics.

What analysts predicted

99.66%UPSIDE

Target Price

$256

Current Price

$0.8649

Analyzed by

6 Analysts

Target

$256.00

Bluejay Diagnostics target price $256, a slight upside of 99.66% compared to current price of $0.8649. According to 6 analysts rating.

Indian Investors' Interest in Bluejay Diagnostics Stock

Search interest for Bluejay Diagnostics Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

Bluejay Diagnostics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-
-
-
-
0
0
-
Operating Income
-2
-1
-1
-1
-1
-1
-1
-1
-1
-2
EBITDA
-2
-1
-1
-1
-1
-1
-1
-1
-1
-2
Interest Expense
-
0
0
0
-
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-2
-2
-1
-1
-1
-1
-1
-1
-1
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-2
-1
-1
-1
-1
-1
-1
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bluejay Diagnostics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
0
-
-
-
Gross Profit
0
0
-
0
0
0
-
Operating Income
-1
-1
-3
-9
-10
-7
-6
EBITDA
-1
-1
-2
-8
-9
-6
-6
Interest Expense
-
0
0
-
-
0
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
0
-1
-3
-9
-9
-7
-6
Income Tax Expense
-
-
-
-
-
-
-
Net Income
0
-1
-3
-9
-9
-7
-6
Net Profit Margin
0.00%
0.00%
0.00%
19.64%
0.00%
0.00%
0.00%

Bluejay Diagnostics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-2
-1
-1
-1
-1
-1
-1
-1
-2
Operating Cash Flow
-2
-1
-1
-1
-1
-2
-1
-1
-1
-1
Investing Cash Flow
0
0
0
0
-
-
-
0
0
0
Financing Cash Flow
2
7
0
0
0
3
0
3
0
7
Change in Cash
0
5
-2
-1
-1
1
-1
2
-1
5

Bluejay Diagnostics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-1
-3
-9
-9
-7
-6
Operating Cash Flow
-1
0
-4
-7
-8
-7
-6
Investing Cash Flow
0
-
0
-1
0
0
0
Financing Cash Flow
1
1
22
0
1
10
7
Change in Cash
0
0
18
-8
-7
2
0

Mutual Funds that own Bluejay Diagnostics Stock

Check out the Mutual Funds with significant holdings in Bluejay Diagnostics.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.202996%
9070

Global Institutional Holdings in Bluejay Diagnostics

Funds
Holdings
Geode Capital Management, LLC
2.72%
Tower Research Capital LLC
0.17%
UBS Group AG
0.01%
L1 Global Manager Pty Ltd
0.01%
Caitong International Asset Management Co., Limited.
0%

Bluejay Diagnostics News & Key Events

  • img

    Today's Timeline - 08 September

    Wed, 02:49 AM

    -

    Bluejay Diagnostics partners with Lovell for federal market access and commercialization of Symphony diagnostic platform post-regulatory clearance.

Insights on Bluejay Diagnostics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 18.7% return, outperforming this stock by 105.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 22.0% return, outperforming this stock by 122.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BJDX stock has moved down by -19.6%

About Bluejay Diagnostics

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
OrganisationBluejay Diagnostics
Headquarters360 Massachusetts Avenue, Acton, MA, United States, 01720
IndustryMedical Devices
CEOMr. Indranil Dey
E-voting on sharesClick here to vote

Key Management of Bluejay Diagnostics

Name

Title

Mr. Indranil Dey

Principal Financial, Accounting & Executive Officer, President, CEO and Director

Mr. Kevin Vance

Chief Commercial Officer

Mr. Mark W. Feinberg M.D., Ph.D.

Chief Medical Advisor

Dr. Mark W. Feinberg M.D.

Chief Medical Advisor

FAQs

What is Bluejay Diagnostics share price today?

Bluejay Diagnostics share price today is $0.86 as on . Bluejay Diagnostics share today touched a day high of $0.87 and a low of $0.81.

What is the 52 week high and 52 week low for Bluejay Diagnostics share?

Bluejay Diagnostics share touched a 52 week high of $16.68 on and a 52 week low of $0.80 on . Bluejay Diagnostics stock price today i.e. is trending at $0.86,which is 94.81% down from its 52 week high and 8.09% up from its 52 week low.

What is Bluejay Diagnostics's market capitalisation today?

Bluejay Diagnostics market capitalisation is $0.00T as on .

How to invest in Bluejay Diagnostics Stock (BJDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bluejay Diagnostics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bluejay Diagnostics Shares that will get you 1.7343 shares as per Bluejay Diagnostics share price of $0.86 per share as on September 17, 2026 at 7:41 pm IST.

What is the minimum amount required to buy Bluejay Diagnostics Stock (BJDX) from India?

Indian investors can start investing in Bluejay Diagnostics (BJDX) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in Bluejay Diagnostics stock (as per the Rupee-Dollar exchange rate as on ). Based on Bluejay Diagnostics share’s latest price of $0.86 as on September 17, 2026 at 7:41 pm IST, you will get 11.5620 shares of Bluejay Diagnostics. Learn more about fractional shares .